Experienced in IgG4-Related Disease

Heidi Olze

Charité Universitätsmedizin
Berlin, BE, DE 
Experienced in IgG4-Related Disease
Charité Universitätsmedizin
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Heidi Olze practices in Berlin, Germany. Ms. Olze is rated as an Experienced expert by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Sinusitis, Nasal Polyps, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Myringotomy, and Septoplasty.

Her clinical research consists of co-authoring 201 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of IgG4-Related Disease.

Gender
Female

Locations

Charité Universitätsmedizin
Berlin, BE, Germany
Other Locations
Mitte, BE 10117, Germany
Tuebingen, BW, Germany
Hannover, NI, Germany
Head and Neck Surgery, Charité Universitätsmedizin BerlinBerlin
Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomized Phase II Study of Two Different Regimens of TPF Induction Chemotherapy Regimen Followed by Radiation Therapy Plus Cetuximab (TPF-CET-HART) vs. HART and Cis-platinum, 5-FU (PF-HART) in Patients With Locally Advanced Unresectable Squamous Cell Carcinomas of the Head and Neck
Randomized Phase II Study of Two Different Regimens of TPF Induction Chemotherapy Regimen Followed by Radiation Therapy Plus Cetuximab (TPF-CET-HART) vs. HART and Cis-platinum, 5-FU (PF-HART) in Patients With Locally Advanced Unresectable Squamous Cell Carcinomas of the Head and Neck
Enrollment Status: Completed
Publish Date: January 31, 2019
Intervention Type: Drug, Radiation
Study Phase: Phase 2

201 Total Publications

Multi-centric real-world effectiveness of mepolizumab in severe chronic rhinosinusitis with nasal polyps in Germany.
Multi-centric real-world effectiveness of mepolizumab in severe chronic rhinosinusitis with nasal polyps in Germany.
Journal: Rhinology
Published: July 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Olze's expertise for a condition
ConditionClose
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile